Imetelstat
Geron Corporation
['mds']
 the number of positive phase 3 trials in mds in the last 25 years can be counted on fingers of one hand, said amer zeidan, &amp; to see 2 positive randomized phase 3 trials in #mdssm in the same session in #asco23 is special &amp; an indication of the progress we've been making 
Associate Prof, Ast Director CTO, Director Heme early phase/#Leuksm research @Yale. @LLSusa Scholar in Clinical Research. Own Opinion. COI https://t.co/6XkF8CmtrK